Healthcare >> CEO Interviews >> October 1, 2001
MICHAEL D. BAER has served as Chief Financial Officer of Insmed
Incorporated and its predecessor company since May 1999. He has more
than 25 years of experience in financial management, most recently from
1995 to 1998 as Controller, Vice President and Chief Financial Officer
of InSite Vision Incorporated, a biopharmaceutical company in the San
Francisco Bay area. He served as Chief Financial Officer for the US
operations of Simsmetal Limited, a publicly held Australian recycling
company, from 1993 to 1994, as the regional Financial and Administrative
Officer for the public accounting firm, Deloitte & Touche from 1990 to
1993, and as the Partner in charge of the Sacramento office of Deloitte,
Haskins & Sells from 1984 to 1990. He is a Certified Public Accountant
and holds an MBA in Finance from the University of California, Berkeley. Profile
TWST: Could we begin with a brief overview of the history and evolutionof Insmed Incorporated?
Mr. Baer: Insmed is a biopharmaceutical company developing products for
diabetes and other